This version of this provision is prospective.
There are outstanding changes not yet made by the legislation.gov.uk editorial team to The Medicines (Advisory Bodies) Regulations 2005. Any changes that have already been made by the team appear in the content and are referenced with annotations.
Prospective
5.—(1) Section 4 of the Act (establishment of committees)(1) shall be amended as follows.
(2) In subsection (1), omit the words from “, having regard to” to “consider appropriate,”.
(3) In subsection (2)(a), before “or the Clinical Trials Regulations”, insert “, the Marketing Authorisation Regulations”.
(4) After subsection (4), insert the following subsection—
“(4A) A committee established under this section shall have at least eight members.”.
(5) For subsection (6), substitute—
“(6) In this Act “the appropriate committee”, for the purposes of any provision of this Act under which a function falls to be performed, means—
(a)in a case where—
(i)a committee has been established under this section for purposes which consist of or include any of those specified in subsection (3) of this section, and
(ii)the authority performing that function considers it to be the appropriate committee in the circumstances,
that committee; and
(b)in any other case, the Commission.”.
Commencement Information
I1Reg. 5 in force at 30.10.2005, see reg. 1(1)
Section 4 was amended by paragraph 15 of Part 3 of Schedule 3 to the Food Standards Act 1999 (c. 28) and by paragraph 2 of Part 1 of Schedule 10 to S.I. 2004/1031.
All content is available under the Open Government Licence v3.0 except where otherwise stated. This site additionally contains content derived from EUR-Lex, reused under the terms of the Commission Decision 2011/833/EU on the reuse of documents from the EU institutions. For more information see the EUR-Lex public statement on re-use.
